AGY Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
AGY Therapeutics is initially focused on studying stroke. It is examining genes the brain switches on in response to damage, on the theory that these gene products might be potential targets for inhibitory therapeutics.